Merck's injected version of its blockbuster cancer drug Keytruda could face a potential patent challenge from biotech Halozyme Therapeutics , the Wall Street Journal reported on Wednesday, citing ...
What is the current share price of Hyperion Global Growth Companies Fund (Managed Fund) (HYGG)? Hyperion Global Growth Companies Fund (Managed Fund)'s (HYGG) current share price is $6.19. This ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback